EOS Imaging, a Paris-based provider of 2D/3D orthopedic medical imaging and related solutions, has received the CE mark for kneeEOS, the company’s 3D planning software for total knee arthroplasty (TKA) based on EOS bi-planar imaging. EOS Imaging recently showcased kneeEOS and the rest of its 3D cloud-based surgical planning suite at the 16th European Federation of National Associations of Orthopaedics and Traumatology (EFORT) Congress, held May 27–29 in Prague.
Like the company’s hipEOS, which received the CE Mark and FDA clearance in 2014, the kneeEOS software is powered by EOS images. This 3D surgical planning platform is based on EOS’ low-dose 3D images and technology from OneFit Medical, a company acquired by EOS imaging in late 2013. It will initially be deployed as an online service to assist surgeons in patient’s leg alignment simulation in functional position, knee prosthesis selection, and placement simulation based upon 3D images generated by the EOS system.
“Leg alignment and component positioning are known to significantly influence surgical outcomes for total knee replacement,” said Marie Meynadier, CEO of EOS imaging. “The kneeEOS is the first and only 3D planning software for TKA in a functional weight bearing position. Following the launch of hipEOS and our EOS 3D Service, kneeEOS marks the continued expansion of our cloud-based services based on EOS unique images and associated patient datasets.”
The EOS system provides full-body stereo-radiographic images of patients in functional positions, in both 2D and 3D. According to the company, EOS exams require a radiation dose 50% to 85% less than digital radiology, and 95% less than basic CT scans. The new EOS Micro Dose option, recently cleared by the FDA, honors the ALARA principle (As Low As Reasonably Achievable) by reducing pediatric spine follow-up exams to a dose level that is equivalent to a week of natural background radiation.
For more information, visit the EOS Imaging website.